C94.11 Chronic erythremia, in remission

Name of the Condition

• Chronic erythremia, in remission
• ICD-10 Code: C94.11

Summary

Chronic erythremia, in remission, is a myeloproliferative neoplasm where the overproduction of red blood cells has been controlled, and disease activity is absent or minimal. This condition involves the bone marrow’s abnormal proliferation of red blood cell precursors, which, when in remission, shows no active signs of progression. It is classified as a chronic hematologic disorder with stable or resolved disease status following treatment.

Causes

The exact cause involves genetic mutations or chromosomal abnormalities in hematopoietic stem cells, leading to uncontrolled proliferation of red blood cell precursors. Contributing factors may include prior exposure to radiation or chemicals, genetic predispositions, or underlying myelodysplastic syndromes.

Risk Factors

• Prior exposure to radiation or chemotherapy
• Genetic syndromes (e.g., Down syndrome)
• Family history of myeloproliferative disorders
• Certain chemical exposures (e.g., benzene)
• Advanced age
• Male gender
• History of myelodysplastic syndromes

Symptoms

• Fatigue or weakness
• Unexplained weight loss
• Headaches or dizziness
• Blurred vision or visual disturbances
• Itching (pruritus)
• Reddish skin tone (plethora)
• Enlarged spleen (splenomegaly)
• Easy bruising or bleeding

Diagnosis

Diagnosis involves a physical examination, followed by blood tests (complete blood count, peripheral smear) to assess red blood cell levels and bone marrow biopsy to confirm remission status. Additional tests may include genetic analysis to identify underlying mutations.

Treatment Options

Treatment focuses on maintaining remission and may include phlebotomy to reduce red blood cell count, low-dose aspirin to prevent clotting, and periodic monitoring. In some cases, targeted therapies or interferon may be used to sustain disease control.

Prognosis and Follow-Up

Prognosis is generally favorable when in remission, with regular follow-up to monitor for recurrence. Lifelong surveillance is recommended to detect any signs of disease reactivation or progression.

Complications

• Thrombotic events (e.g., blood clots)
• Hemorrhagic complications
• Transformation to acute leukemia
• Splenic enlargement or rupture
• Gout or kidney stones

Lifestyle & Prevention

• Stay hydrated to support blood flow.
• Avoid smoking and excessive alcohol.
• Maintain a balanced diet to support overall health.
• Follow up with healthcare providers as scheduled.

When to Seek Professional Help

Seek immediate care for severe symptoms like chest pain, shortness of breath, or uncontrolled bleeding. Regular check-ups are advised to monitor remission status.

Tips for Medical Coders

Document remission status clearly in clinical notes, as this code specifies the condition is in remission. Ensure supporting documentation aligns with the absence of active disease activity to justify the code assignment.